Antifungal Amphiphilic Aminoglycosides.

Area of Science:

• Medicinal Chemistry
• Mycology
• Drug Discovery

Background:

• Traditional aminoglycosides like kanamycin and neomycin are primarily antibacterial.
• Modifying these drugs with hydrophobic groups can alter their antimicrobial spectrum.
• Developing new antifungal agents is crucial due to increasing drug resistance.

Purpose of the Study:

• To review the discovery and properties of amphiphilic kanamycins.
• To investigate their potential as novel antifungal agents.
• To explore their mechanism of action and toxicity profile.

Main Methods:

• Chemical modification of existing antibacterial drugs (kanamycins, neomycins).
• Antifungal activity screening against various fungal pathogens.
• Mechanism of action studies focusing on plasma membrane perturbation.
• Cytotoxicity assays on plant and mammalian cell lines.

Main Results:

• Amphiphilic kanamycins exhibit significant antifungal activity.
• These compounds are not antibacterial, indicating a selective spectrum.
• Inhibition of fungal growth occurs via disruption of plasma membrane functions.
• Low toxicity observed against non-target plant and mammalian cells.

Conclusions:

• Amphiphilic kanamycins represent a new class of antifungal agents.
• They specifically target fungal plasma membranes, offering a selective advantage.
• Reviving and repurposing existing drug scaffolds can address new therapeutic challenges.
• These compounds show promise for developing new strategies against fungal pathogens.